BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17893971)

  • 21. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
    Xing Q; Su H; Cui J; Wang B
    Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
    Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
    Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.
    Morita K; Okamura T; Inoue M; Komai T; Teruya S; Iwasaki Y; Sumitomo S; Shoda H; Yamamoto K; Fujio K
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8131-E8140. PubMed ID: 27911796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
    Robak E; Błoński JZ; Bartkowiak J; Niewiadomska H; Sysa-Jedrzejowska A; Robak T
    Mediators Inflamm; 1999; 8(6):305-12. PubMed ID: 10815619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
    Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
    Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tregs in SLE: an Update.
    La Cava A
    Curr Rheumatol Rep; 2018 Feb; 20(2):6. PubMed ID: 29464438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tregs are regulated by cytokines: implications for autoimmunity.
    La Cava A
    Autoimmun Rev; 2008 Oct; 8(1):83-7. PubMed ID: 18771756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory T cells and systemic lupus erythematosus.
    Mudd PA; Teague BN; Farris AD
    Scand J Immunol; 2006 Sep; 64(3):211-8. PubMed ID: 16918689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
    Valencia X; Yarboro C; Illei G; Lipsky PE
    J Immunol; 2007 Feb; 178(4):2579-88. PubMed ID: 17277168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets.
    Kang HK; Michaels MA; Berner BR; Datta SK
    J Immunol; 2005 Mar; 174(6):3247-55. PubMed ID: 15749855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.
    Mizui M; Tsokos GC
    Front Immunol; 2018; 9():786. PubMed ID: 29755456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4(+)FoxP3(+) regulatory T-cells in human systemic lupus erythematosus.
    Suen JL; Chiang BL
    J Formos Med Assoc; 2012 Sep; 111(9):465-70. PubMed ID: 23021502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The significance of regulatory CD4+CD25+ T cells in the pathogenesis and treatment of kidney disease].
    Krajewska M; Weyde W; Klinger M
    Postepy Hig Med Dosw (Online); 2007; 61():178-84. PubMed ID: 17507865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conserved anti-proliferative effect and poor inhibition of TNFalpha secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus.
    Gómez J; Prado C; López P; Suárez A; Gutiérrez C
    Clin Immunol; 2009 Sep; 132(3):385-92. PubMed ID: 19540813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of T Cell Activation and Differentiation by Extracellular Vesicles and Their Pathogenic Role in Systemic Lupus Erythematosus and Multiple Sclerosis.
    Ulivieri C; Baldari CT
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28157168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
    Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
    Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
    Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
    Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.
    Bonelli M; Savitskaya A; Steiner CW; Rath E; Smolen JS; Scheinecker C
    J Immunol; 2009 Feb; 182(3):1689-95. PubMed ID: 19155519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
    Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
    Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propagation and regulation of systemic autoimmunity by gammadelta T cells.
    Peng SL; Madaio MP; Hayday AC; Craft J
    J Immunol; 1996 Dec; 157(12):5689-98. PubMed ID: 8955223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.